Aditxt Inc

Research Aditxt Inc (ADTX) on Bullrun: market cap USD 93. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerADTX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 93
• Financial periodFY2025
• RevenueUSD 3.20K
• Revenue growth-97.6%
• Net income-USD 43.10M
• Free cash flow-USD 25.70M
• Gross margin8.4%

Valuation Snapshot

latest market cap is USD 93.

About Aditxt Inc

Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It develops ADI-100 for skin grafting, psoriasis, and type-1 diabetes.

Frequently asked questions

What is Aditxt Inc's market cap?

Aditxt Inc's market capitalization is USD 93.

What does Aditxt Inc do?

Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system;